1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.
2.
Viswanathan AN, Creutzberg CL, Craighead P et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012; 82: 250-255.
3.
Guedea F, Venselaar J, Hoskin P et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol 2010; 97: 514-520.
4.
Kumar A, Chopra S, Mahantshetty U et al. Brachytherapy in India: Learning from the past and looking into the future. Brachytherapy 2020; 19: 861-873.
5.
Implementation of High Dose Rate Brachytherapy in Limited Resource Settings. IAEA Human Health Series No. 30. International Atomic Energy Agency Vienna, 2015. https://www.iaea.org/publications/10355. [Last accessed on June 28, 2024].
6.
Lee LJ, Das IJ, Higgins SA et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: Low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy 2012; 11: 53-57.
7.
Swift PS, Purser P, Roberts LW et al. Pulsed low dose rate brachytherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys 1997; 37: 811-817.
8.
Charra-Brunaud C, Harter V, Delannes M et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012; 103: 305-313.
9.
Balgobind BV, Koedooder K, Ordoñez Zúñiga D et al. A review of the clinical experience in pulsed dose rate brachytherapy. Br J Radiol 2015; 88: 20150310.
10.
ACOG Technical Bulletin No. 155. Classification and staging of gynaecologic malignancies. Int J Gynecol Obstet 1992; 38: 319-323.
11.
ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units & Measurements; 1985.
12.
Stout R, Hunter RD. Clinical trials of changing dose rate in intracavitary low dose rate therapy. In: Mould RF (Ed.). Braehytherapy-2. Nucletron International BV, Leersum, The Netherlands 1989; 219-222.
13.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
14.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
15.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
16.
Liu R, Wang X, Tian JH et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev 2014; 10: CD007563.
17.
Petereit DG, Sarkaria JN, Potter DM et al. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence – The University of Wisconsin experience. Int J Radiat Oncol Biol Phys 1999; 45: 1267-1274.
18.
Ferrigno R, Nishimoto IN, Novaes PE et al. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer: retrospective analysis of two sequential series. Int J Radiat Oncol Biol Phys 2005; 62: 1108-1116.
19.
Kucera H, Potter R, Knocke TH et al. High dose versus low dose rate brachytherapy in definitive radiotherapy of cervical cancer. Wien Klin Wochenschr 2001; 113: 58-62.
20.
Kumar P, Sharma DN, Kumar S et al. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study. Brachytherapy 2016; 15: 327-332.
21.
Lee KK, Lee JY, Nam JM et al. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: systematic review and meta-analysis. Brachytherapy 2015; 14: 449-457.
22.
Stewart AJ, Viswanathan AN. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer 2006; 107: 908-915.
23.
Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-5812.
24.
Pearcey R, Brundage M, Drouin P et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-972.
25.
Tseng CJ, Chang CT, Lai CH et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997; 66: 52-58.
